Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3729910012 | Buprenorphine only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3729911011 | Product containing only buprenorphine (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Buprenorphine only product | Is a | Medicinal product (product) | true | Inferred relationship | Some | ||
| Buprenorphine only product | Has active ingredient | Buprenorphine (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch | Is a | True | Buprenorphine only product | Inferred relationship | Some | |
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch | Is a | True | Buprenorphine only product | Inferred relationship | Some | |
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | True | Buprenorphine only product | Inferred relationship | Some | |
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | True | Buprenorphine only product | Inferred relationship | Some | |
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch | Is a | True | Buprenorphine only product | Inferred relationship | Some |
Reference Sets
FHIR